Helex

New York, United States

Enabling Safer Gene Editing

$3.5M raised

Oct 2025

Seed

Top Investors

SOSVPi VenturesIndieBioBluehill Capital

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Helex raised?

Helex has raised $3.5M in total funding. The most recent round was Seed. The last funding was announced in October 2025.

Who are Helex's investors?

Helex's investors include SOSV, Pi Ventures, IndieBio, Bluehill Capital.

Where is Helex headquartered?

Helex is headquartered in New York, United States.

What does Helex do?

Enabling Safer Gene Editing

What stage is Helex at?

Helex is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated October 30, 2025.

MLA

"Helex — Funding & Investors." VCBacked, October 30, 2025, https://www.vcbacked.co/company/helex. Accessed June 3, 2026.

APA

VCBacked. (2025). Helex — Funding & Investors. Retrieved June 3, 2026, from https://www.vcbacked.co/company/helex

Wikipedia (cite web)

{{cite web |title=Helex — Funding & Investors |url=https://www.vcbacked.co/company/helex |website=VCBacked |access-date=June 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated October 30, 2025.